Timothy P. Coughlin

2016

In 2016, Timothy P. Coughlin earned a total compensation of $4.3M as Chief Financial Officer at Neurocrine Biosciences, a 54% increase compared to previous year.

Compensation breakdown

Bonus$195,615
Option Awards$2,364,830
Salary$434,700
Stock Awards$1,250,608
Other$36,058
Total$4,281,811

Coughlin received $2.4M in option awards, accounting for 55% of the total pay in 2016.

Coughlin also received $195.6K in bonus, $434.7K in salary, $1.3M in stock awards and $36.1K in other compensation.

Rankings

In 2016, Timothy P. Coughlin's compensation ranked 2,011th out of 14,075 executives tracked by ExecPay. In other words, Coughlin earned more than 85.7% of executives.

ClassificationRankingPercentile
All
2,011
out of 14,075
86th
Division
Manufacturing
688
out of 5,486
88th
Major group
Chemicals And Allied Products
196
out of 1,900
90th
Industry group
Drugs
140
out of 1,543
91st
Industry
Biological Products, Except Diagnostic Substances
26
out of 287
91st
Source: SEC filing on April 20, 2017.

Coughlin's colleagues

We found five more compensation records of executives who worked with Timothy P. Coughlin at Neurocrine Biosciences in 2016.

2016

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2016

Christopher O'Brien

Neurocrine Biosciences

Chief Medical Officer

2016

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

2016

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2016

Kyle Gano

Neurocrine Biosciences

Chief Business Development Officer

In-depth

You may also like